ES2137878B1 - PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. - Google Patents
PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE.Info
- Publication number
- ES2137878B1 ES2137878B1 ES9702496A ES9702496A ES2137878B1 ES 2137878 B1 ES2137878 B1 ES 2137878B1 ES 9702496 A ES9702496 A ES 9702496A ES 9702496 A ES9702496 A ES 9702496A ES 2137878 B1 ES2137878 B1 ES 2137878B1
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- obtaining
- therapeutic use
- plasma
- human plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 title abstract 2
- 230000002238 attenuated effect Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 210000002381 plasma Anatomy 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 239000004023 fresh frozen plasma Substances 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 238000000108 ultra-filtration Methods 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Procedimiento de obtención de un plasma humano atenuado de virus para uso terapéutico. El procedimiento se caracteriza porque la mezcla del plasma tratado es estabilizado y protegida contra la degradación, siendo los restos de los reactivos empleados en el método de inactivación eliminados por adsorción con una resina selectiva, complementándose con una concentración por ultrafiltración hasta obtener un plasma cuya composición proteica es equivalente al plasma fresco congelado y es apto para su transfusión.Procedure for obtaining an attenuated virus human plasma for therapeutic use. The procedure is characterized in that the mixture of the treated plasma is stabilized and protected against degradation, the remains of the reagents used in the inactivation method being removed by adsorption with a selective resin, complemented by concentration by ultrafiltration until obtaining a plasma whose composition Protein is equivalent to fresh frozen plasma and is suitable for transfusion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9702496A ES2137878B1 (en) | 1997-12-01 | 1997-12-01 | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9702496A ES2137878B1 (en) | 1997-12-01 | 1997-12-01 | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2137878A1 ES2137878A1 (en) | 1999-12-16 |
| ES2137878B1 true ES2137878B1 (en) | 2000-10-01 |
Family
ID=8301352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES9702496A Expired - Fee Related ES2137878B1 (en) | 1997-12-01 | 1997-12-01 | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2137878B1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4142908C2 (en) * | 1991-12-24 | 1994-02-10 | Octapharma Ag Glarus | Method for producing a virus-inactivated prothrombin complex concentrate (PPSB) |
| DE4337573C1 (en) * | 1993-11-04 | 1995-05-18 | Octapharma Ag | Process for the preparation of a virus-inactivated factor VIII-containing fraction by means of chromatographic methods |
-
1997
- 1997-12-01 ES ES9702496A patent/ES2137878B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2137878A1 (en) | 1999-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26724A1 (en) | METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUSES | |
| EA200000994A1 (en) | APPLICATION OF KABERGOLIN IN TREATING SYNDROME TIRED FOOT | |
| MX9205240A (en) | COMPOSITION AND METHOD FOR TREATING HEPATITIS C. | |
| AR013670A1 (en) | DEVICE FOR THE TREATMENT OF VARICOSE VEINS | |
| DE69835279D1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS USING CATIONIC PEPTIDES ALONE OR IN COMBINATION WITH ANTIBIOTICS | |
| ID29393A (en) | COMPOSITION OF CANCER TREATMENT AND METHOD OF USING NATURAL PLANT ESENSIL OILS | |
| ATE106740T1 (en) | PREPARATION OF T-CELLS AND T-CELL MEMBRANES USABLE FOR PREVENTING AND TREATMENT OF AUTOIMMUNE DISEASES. | |
| NZ334270A (en) | Glucagon like peptide (GLP-1), analogs and derivatives to treat post surgical catabolic changes and insulin resistance | |
| NO951761L (en) | Stable preparation for the treatment of blood coagulation disorders | |
| RU94022754A (en) | Method for preventing and treating ischemia attacks and reperfusion-induced injuries influenced by the attacks | |
| ES2045895T3 (en) | PROCEDURE FOR THE MICROBIOLOGICAL DECONTAMINATION OF THE SOIL. | |
| ATE258791T1 (en) | LIPOXIN-A4 AND THEIR ANALOGUES FOR THE TREATMENT OF DRY EYES | |
| FI961536A0 (en) | Procedure for inactivating viruses in the presence of polyalkylene glycol and thus obtained pharmaceutical preparation | |
| DK1001775T3 (en) | Medication containing yohimbine and arginine intended to treat erectile dysfunction | |
| AR006023A1 (en) | VACCINE AGAINST SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME | |
| EP0214017A3 (en) | Use of n,n,-dimethylbiguanid p-chorophenoxyacetate in the treatment of neuropathies and nerval degeneration | |
| DE50108409D1 (en) | TREATMENT OF SURFACES FOR THE TEMPORARY IMPROVEMENT OF DIRT-RELATED BEHAVIOR | |
| ES2178405T3 (en) | USE OF SELEGYLINE OR DEMETILSELEGILINE TO TREAT WOUNDS, BURNS AND SKIN INJURIES. | |
| ES2113910T3 (en) | PROCEDURE FOR THE PREPARATION OF A TROMBINE CONCENTRATE INSURED AGAINST VIRUSES. | |
| ES2137878B1 (en) | PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE. | |
| EP0434470A3 (en) | Protection against chemically-induced kidney damage by methimazole | |
| ATE544453T1 (en) | COMBINATION THERAPIES WITH L-FMAU FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS | |
| DE69927815D1 (en) | INOSITOLPHOSPHOGLYCAN AND RIBOSE FOR THE TREATMENT OF ISCHEMIC REPERFUSION DAMAGE | |
| DE69808663D1 (en) | NEOMYCIN / DISACCHARID AQUEOUS SOLUTION FOR TREATING ENTEROCLYSIS IN HEPATIC ENZEPHALOPATHY | |
| EA200100223A3 (en) | Water dispersed ivermectin dosage form for curing ecto- endoparasitic diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 19991216 Kind code of ref document: A1 Effective date: 19991216 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20180326 |